Last reviewed · How we verify

NCT03901794

Relationship Between Hemodynamic Change and Fluid Removed During Hemodialysis

Completed Last updated 3 April 2019
What this trial tests

trial testing Non-invasive hemodynamic monitor in Hemodialysis Complication in 60 participants. Completed in 30 November 2018.

Timeline
6 May 2017
Primary endpoint
23 November 2018
30 November 2018

Quick facts

Lead sponsorNational Taiwan University Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment60
Start date6 May 2017
Primary completion23 November 2018
Estimated completion30 November 2018
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

National Taiwan University Hospital

Who can join

20 and older, any sex, with Hemodialysis Complication or Hemodialysis-Induced Symptom. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Relationship between hemodynamic change and fluid removed during hemodialysis measured by non-invasive monitor

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Detecting Volemic, Cardiac, and Autonomic Responses From Hypervolemia to Normovolemia <i>via</i> Non-Invasive ClearSight Hemodynamic Monitoring During Hemodialysis: An Observational Investigation.
    Lai CJ, Shih CC, Huang HH, Chien MH, et al · · 2022 · cited 3× · PMID 35574491 · DOI 10.3389/fphys.2022.775631

Verify or expand the search:

Other recruiting trials for Hemodialysis Complication

Currently open trials in the same condition.

Other National Taiwan University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03901794.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing